APOA1 and melanoma: Herein, we used differential gene expression analysis of primary B16F10L melanoma homografts to investigate the role of host apoA-I in the tumor microenvironment, and identified the mevalonate and de novo serine synthesis metabolic pathways as potential targets of apoA-I anti-tumor activity.